Clinical Trials Browser

Pancreatic Neoplasms × lanreotide × Gastrointestinal × Clear all

NCT06807437 2025-12-05

Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula

Phase 3 Recruiting

Gastrointestinal

Pancreatic Neoplasms